Literature DB >> 30399649

NO as a multimodal transmitter in the brain: discovery and current status.

John Garthwaite1.   

Abstract

NO operates throughout the brain as an intercellular messenger, initiating its varied physiological effects by activating specialized GC-coupled receptors, resulting in the formation of cGMP. In line with the widespread expression of this pathway, NO participates in numerous different brain functions. This review gives an account of the discovery of NO as a signalling molecule in the brain, experiments that originated in the search for a mysterious cGMP-stimulating factor released from central neurones when their NMDA receptors were stimulated, and summarizes the subsequent key steps that helped establish its status as a central transmitter. Currently, various modes of operation are viewed to underlie its diverse behaviour, ranging from very local signalling between synaptic partners (in the orthograde or retrograde directions) to a volume-type transmission whereby NO synthesized by multiple synchronous sources summate spatially and temporally to influence intermingled neuronal or non-neuronal cells, irrespective of anatomical connectivity. LINKED ARTICLES: This article is part of a themed section on Nitric Oxide 20 Years from the 1998 Nobel Prize. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.2/issuetoc.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30399649      PMCID: PMC6295412          DOI: 10.1111/bph.14532

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  133 in total

1.  Neuronal NADPH diaphorase is a nitric oxide synthase.

Authors:  B T Hope; G J Michael; K M Knigge; S R Vincent
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.

Authors:  B Roy; E Mo; J Vernon; J Garthwaite
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

3.  NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at pre- and postsynaptic sites and in spines.

Authors:  C Aoki; J Rhee; M Lubin; T M Dawson
Journal:  Brain Res       Date:  1997-03-07       Impact factor: 3.252

4.  Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.

Authors:  Mizanur M Rahaman; Anh T Nguyen; Megan P Miller; Scott A Hahn; Courtney Sparacino-Watkins; Soma Jobbagy; Nolan T Carew; Nadiezhda Cantu-Medellin; Katherine C Wood; Catherine J Baty; Francisco J Schopfer; Eric E Kelley; Mark T Gladwin; Emil Martin; Adam C Straub
Journal:  Circ Res       Date:  2017-06-05       Impact factor: 17.367

5.  "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.

Authors:  T C Bellamy; J Garthwaite
Journal:  Mol Pharmacol       Date:  2001-01       Impact factor: 4.436

6.  Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

7.  Cellular uptake disguises action of L-glutamate on N-methyl-D-aspartate receptors. With an appendix: diffusion of transported amino acids into brain slices.

Authors:  J Garthwaite
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

8.  NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.

Authors:  Johannes-Peter Stasch; Peter Schmidt; Cristina Alonso-Alija; Heiner Apeler; Klaus Dembowsky; Michael Haerter; Markus Heil; Torsten Minuth; Elisabeth Perzborn; Ulrich Pleiss; Matthias Schramm; Werner Schroeder; Henning Schröder; Elke Stahl; Wolfram Steinke; Frank Wunder
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  NO enhances presynaptic currents during cerebellar mossy fiber-granule cell LTP.

Authors:  Arianna Maffei; Francesca Prestori; Katsuei Shibuki; Paola Rossi; Vanni Taglietti; Egidio D'Angelo
Journal:  J Neurophysiol       Date:  2003-10       Impact factor: 2.714

Review 10.  What is the real physiological NO concentration in vivo?

Authors:  Catherine N Hall; John Garthwaite
Journal:  Nitric Oxide       Date:  2009-07-12       Impact factor: 4.427

View more
  21 in total

1.  Nitric Oxide Signaling Strengthens Inhibitory Synapses of Cerebellar Molecular Layer Interneurons through a GABARAP-Dependent Mechanism.

Authors:  Erik A Larson; Michael V Accardi; Ying Wang; Martina D'Antoni; Benyamin Karimi; Tabrez J Siddiqui; Derek Bowie
Journal:  J Neurosci       Date:  2020-03-13       Impact factor: 6.167

Review 2.  NO as a multimodal transmitter in the brain: discovery and current status.

Authors:  John Garthwaite
Journal:  Br J Pharmacol       Date:  2018-12-05       Impact factor: 8.739

Review 3.  Chemiluminescence Measurement of Reactive Sulfur and Nitrogen Species.

Authors:  Bo Li; Yujin Lisa Kim; Alexander Ryan Lippert
Journal:  Antioxid Redox Signal       Date:  2021-10-22       Impact factor: 7.468

Review 4.  Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.

Authors:  Napatsorn Saiyasit; Evan-Angelo R Butlig; Samantha D Chaney; Miranda K Traylor; Nanako A Hawley; Ryleigh B Randall; Hanna V Bobinger; Carl A Frizell; Franklin Trimm; Errol D Crook; Mike Lin; Benjamin D Hill; Joshua L Keller; Amy R Nelson
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

5.  Nicotine Facilitates Facial Stimulation-Evoked Mossy Fiber-Granule Cell Long-Term Potentiation in vivo in Mice.

Authors:  Li-Xin Cao; Yan-Hua Bing; Yin-Hua Xu; Guang-Jian Zhang; Chun-Ping Chu; Lan Hong; De-Lai Qiu
Journal:  Front Cell Neurosci       Date:  2022-07-04       Impact factor: 6.147

6.  The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases.

Authors:  Susana S Correia; Rajesh R Iyengar; Peter Germano; Kim Tang; Sylvie G Bernier; Chad D Schwartzkopf; Jenny Tobin; Thomas W-H Lee; Guang Liu; Sarah Jacobson; Andrew Carvalho; Glen R Rennie; Joon Jung; Paul A Renhowe; Elisabeth Lonie; Christopher J Winrow; John R Hadcock; Juli E Jones; Mark G Currie
Journal:  Front Pharmacol       Date:  2021-05-24       Impact factor: 5.810

Review 7.  A review of the actions of Nitric Oxide in development and neuronal function in major invertebrate model systems.

Authors:  Nicholas J D Wright
Journal:  AIMS Neurosci       Date:  2019-08-19

Review 8.  Role of nitric oxide in psychostimulant-induced neurotoxicity.

Authors:  Valentina Bashkatova; Athineos Philippu
Journal:  AIMS Neurosci       Date:  2019-09-03

9.  Exercise-Induced Elevated BDNF Level Does Not Prevent Cognitive Impairment Due to Acute Exposure to Moderate Hypoxia in Well-Trained Athletes.

Authors:  Zofia Piotrowicz; Małgorzata Chalimoniuk; Kamila Płoszczyca; Miłosz Czuba; Józef Langfort
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

Review 10.  Nitric oxide regulates the firing rate of neuronal subtypes in the guinea pig ventral cochlear nucleus.

Authors:  Adam Hockley; Joel I Berger; Paul A Smith; Alan R Palmer; Mark N Wallace
Journal:  Eur J Neurosci       Date:  2019-10-10       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.